Short answer
Altimmune, Inc. (ALT) filed an 8-K current report with the SEC on March 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 earnings announced March 5, 2026; full results in Exhibit 99.1 press release.
Altimmune, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings announced March 5, 2026; full results in Exhibit 99.1 press release
- Reporting period: fiscal year ended December 31, 2025
- Item 2.02 filing signals results are furnished (not filed), meaning no SEC liability attached to the figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Altimmune, Inc. 8-K filings
Get the next ALT 8-K as it lands
Follow ALT for push alerts, or ask the research agent what this filing means.